Safety and Efficacy of R0.6C Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

June 29, 2022

Study Completion Date

June 29, 2022

Conditions
MalariaMalaria,Falciparum
Interventions
BIOLOGICAL

R0.6C transmission blocking vaccine

Vaccination with R0.6C transmission blocking vaccine. Volunteers will sequentially receive four administrations of R0.6C intramuscularly in the deltoid muscle on alternating sides on days 0, 28, 56 and 168.

Trial Locations (1)

6525GA

Radboud university medical center, Nijmegen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Statens Serum Institut

OTHER

collaborator

Novavax

INDUSTRY

lead

Radboud University Medical Center

OTHER